Trial of COVID-19 Booster Vaccine Opens in Autoimmune Diseases

Trial of COVID-19 Booster Vaccine Opens in Autoimmune Diseases

304585

Trial of COVID-19 Booster Vaccine Opens in Autoimmune Diseases

An enrolling clinical trial is assessing whether a “booster shot” of a COVID-19 vaccine can improve the immune response in people with scleroderma and other autoimmune diseases who did not respond, at all or optimally, to their original COVID-19 vaccine regimen. The study also will test whether temporarily stopping medications that suppress the immune system improves the body’s response to an extra dose of COVID-19 vaccine among these individuals. Autoimmune diseases are marked by the…

You must be logged in to read/download the full post.